| 000 | 01915 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250513221854.0 | ||
| 264 | 0 | _c20001025 | |
| 008 | 200010s 0 0 eng d | ||
| 022 | _a0732-183X | ||
| 024 | 7 |
_a10.1200/JCO.2000.18.19.3378 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMeric, F | |
| 245 | 0 | 0 |
_aImpact of neoadjuvant chemotherapy on postoperative morbidity in soft tissue sarcomas. _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cOct 2000 |
||
| 300 |
_a3378-83 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aDoxorubicin _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIfosfamide _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMorbidity |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 |
_aNeoadjuvant Therapy _xadverse effects |
| 650 | 0 | 4 |
_aPostoperative Complications _xepidemiology |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aSarcoma _xdrug therapy |
| 650 | 0 | 4 |
_aSoft Tissue Neoplasms _xdrug therapy |
| 700 | 1 | _aMilas, M | |
| 700 | 1 | _aHunt, K K | |
| 700 | 1 | _aHess, K R | |
| 700 | 1 | _aPisters, P W | |
| 700 | 1 | _aHildebrandt, G | |
| 700 | 1 | _aPatel, S R | |
| 700 | 1 | _aBenjamin, R S | |
| 700 | 1 | _aPlager, C | |
| 700 | 1 | _aPapadopolous, N E | |
| 700 | 1 | _aBurgess, M A | |
| 700 | 1 | _aPollock, R E | |
| 700 | 1 | _aFeig, B W | |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 18 _gno. 19 _gp. 3378-83 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.2000.18.19.3378 _zAvailable from publisher's website |
| 999 |
_c10959082 _d10959082 |
||